These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2882569)

  • 1. Reversible airway obstruction: neurohumoral mechanisms and treatment. Lecture on asthma: clinical overview.
    Flenley DC
    Respiration; 1986; 50 Suppl 2():57-64. PubMed ID: 2882569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible airway obstruction: neurohumoral mechanisms and treatment. Lecture on nocturnal asthma.
    Flenley DC
    Respiration; 1986; 50 Suppl 2():77-82. PubMed ID: 2882570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalation therapy for bronchial asthma: strategies and targets.
    Magnussen H
    Curr Opin Pulm Med; 2003 Apr; 9 Suppl 1():S3-7. PubMed ID: 12974535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peripheral airway obstruction and treatment].
    Horie T; Koyama S; Ohmori C; Ohtsuka A; Koyama S; Mutoh T; Majima T; Yamaguchi M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1617-23. PubMed ID: 1447836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug clinics. Drug of the month. Formoterol (Oxis turbohaler)].
    Scheen AJ
    Rev Med Liege; 1998 Nov; 53(11):715-8. PubMed ID: 9887666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of asthma in children in Papua New Guinea.
    Vince JD
    P N G Med J; 1996 Dec; 39(4):329-37. PubMed ID: 10214092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalation steroids, some aspects and ways in the management of asthma.
    Majumdar SP; Kumar TR
    J Indian Med Assoc; 1994 Jul; 92(7):233-4. PubMed ID: 7963605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Today's treatment of airway obstruction ... and tomorrow's?
    Flenley DC
    Respiration; 1989; 55 Suppl 2():4-9. PubMed ID: 2572039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise and the asthmatic.
    Bundgaard A
    Sports Med; 1985; 2(4):254-66. PubMed ID: 3161167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmeterol xinafoate: a review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.
    Brogden RN; Faulds D
    Allergol Immunopathol (Madr); 1992; 20(2):72-84. PubMed ID: 1359777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative assessment of a new breath-actuated inhaler in patients with reversible airways obstruction.
    Waterhouse JC; Simmons JL; Wray H; Howard P
    Respiration; 1992; 59(3):155-8. PubMed ID: 1439226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nebulized sodium cromoglycate on adult patients with severe refractory asthma.
    Sano Y; Adachi M; Kiuchi T; Miyamoto T
    Respir Med; 2006 Mar; 100(3):420-33. PubMed ID: 16095893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of a powder inhaler (Turbuhaler) in moderate asthmatic crises in children].
    Rufin P; Benoist MR; Panqueva P; Brouard JJ; De Blic J; Scheinmann P
    Rev Mal Respir; 1993; 10(6):545-50. PubMed ID: 8122021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Round Table: Severe asthma in pediatrics: treatment of acute crises].
    García Martínez JM
    Allergol Immunopathol (Madr); 1999; 27(2):53-62. PubMed ID: 10354007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three treatment regimens of inhaled sodium cromoglycate in the management of adult patients with severe, steroid-dependent asthma.
    Sakai H; Shimoda T; Matsuo N; Matsuse H; Obase Y; Asai S; Kohno S; Edwards A
    Ann Allergy Asthma Immunol; 1998 Jun; 80(6):494-8. PubMed ID: 9647273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics.
    Lipworth BJ; Struthers AD; McDevitt DG
    Am Rev Respir Dis; 1989 Sep; 140(3):586-92. PubMed ID: 2782734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic optimisation of asthma treatment.
    Taburet AM; Schmit B
    Clin Pharmacokinet; 1994 May; 26(5):396-418. PubMed ID: 7914480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiotropium may improve asthma symptoms and lung function in asthmatic patients with irreversible airway obstruction: the real-life data.
    Abadoglu O; Berk S
    Clin Respir J; 2016 Jul; 10(4):421-7. PubMed ID: 25335652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.